Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Clinical Psychopharmacology|March 31, 2015
HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in SchizophreniaYoshiteru Takekita, Chiara Fabbri, Masaki Kato, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 29, 2015
Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trialYoshiteru Takekita, Chiara Fabbri, Masaki Kato, et al.
Neuropsychopharmacology Reports|November 6, 2023
Optimal dose for the efficacy of asenapine in patients with schizophrenia: Real-world dataYoshiteru Takekita, Shuichi Hiraoka, Yasuhiro Iwama, et al.
Dementia and Geriatric Cognitive Disorders Extra|December 3, 2015
Neuropsychological Evaluation and Cerebral Blood Flow Effects of Apolipoprotein E4 in Alzheimer's Disease Patients after One Year of Treatment: An Exploratory StudyAzusa Suwa, Keiichiro Nishida, Keita Utsunomiya, et al.
Annals of General Psychiatry|August 2, 2024
Predictors of continuation for asenapine from real-world data in patients with schizophreniaYoshiteru Takekita, Shuichi Hiraoka, Yasuhiro Iwama, et al.
CNS Spectrums|January 19, 2021
Divergence of dose-response with asenapine: a cluster analysis of randomized, double-blind, and placebo control studyYoshiteru Takekita, Shuichi Hiraoka, Yasuhiro Iwama, et al.
Neuropsychobiology|August 10, 2023
Effectiveness and Changes in Brain Functions by an Occupational Therapy Program Incorporating Mindfulness in Outpatients with Anxiety and Depression: A Randomized Controlled TrialAtsuko Yamamoto, Banri Tsukuda, Shota Minami, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 23, 2022
Pre-treatment plasma cytokine levels as potential predictors of short-term remission of depressionKiyokazu Atake, Hikaru Hori, Yuki Kageyama, et al.
CNS Drugs|December 4, 2025
A 12-Week, Open-Label, Multicenter Pilot Study to Evaluate the Efficacy and Safety of Lemborexant in Patients with Insomnia Comorbid with Depressive Episodes (SELENADE)Yoshikazu Takaesu, Hiroyuki Muraoka, Masahiro Takeshima, et al.
Schizophrenia Research. Cognition|July 26, 2017
Cognitive insight and functional outcome in schizophrenia; a multi-center collaborative study with the specific level of functioning scale-Japanese versionTomiki Sumiyoshi, Keiichiro Nishida, Hidehito Niimura, et al.
Pageof 4